SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-022876
Filing Date
2017-04-11
Accepted
2017-04-11 16:15:42
Documents
2
Period of Report
2017-04-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-11142_18k.htm 8-K 36818
2 EX-10.1 a17-11142_1ex10d1.htm EX-10.1 51080
  Complete submission text file 0001104659-17-022876.txt   89071
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37691 | Film No.: 17756086
SIC: 2834 Pharmaceutical Preparations